Published 2009
| Version v1.0.0
Journal Article
Open
Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with ADHD
Creators
Abstract
The short-term and longer-term cardiovascular safety of high daily doses of OROS methylphenidate (MPH) of up to 1.5 mg/kg in 114 adolescents with ADHD is reported from Massachusetts General Hospital, Boston, MA.Files
PNB-23-61-a.pdf
Files
(142.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:37af23056164189f02b9198c2e737e29
|
142.3 kB | Preview Download |
Additional details
Identifiers
- Other
- PNB-23-61-a
Dates
- Created
-
2009When the item was originally created.